Avaliação pré-clínica da duloxetina em modelo de convulsão: análise comportamental, eletroencefalográfica e influência no estresse oxidativo

O transtorno epiléptico apresenta alta prevalência e severidade. Além da gravidade da epilepsia per se, este distúrbio pode ser acompanhado de várias comorbidades, sendo a depressão a principal comorbidade psiquiátrica. Os mecanismos envolvidos na relação epilepsia/depressão ainda não estão bem esclarecidos, e sabe-se que o tratamento de ambos os distúrbios pode ser problemático, já que alguns anticonvulsivantes podem causar ou aumentar sintomas depressivos, enquanto alguns antidepressivos parecem aumentar a susceptibilidade a convulsões. Por outro lado, estudos têm demonstrado que alguns antidepressivos, além de seguros, também possuem atividade anticonvulsivante como a venlafaxina, um inibidor da recaptação de serotonina e noradrenalina (IRSN). Considerando que a duloxetina, outro IRSN, apresenta uma inibição mais potente sobre transportados monoaminérgicos e que não existe nada na literatura a respeito de sua influência sobre convulsões apesar de que está sendo aplicado atualmente na clínica, o objetivo do nosso estudo é verificar o possível efeito anticonvulsivante da duloxetina através do modelo de convulsões induzidas pelo pentilenotetrazol (PTZ) em camundongos. Para tal, camundongos foram pré-tratados com duloxetina (10, 20, 40 mg/kg/i.p.) e trinta minutos após receberam uma injeção intraperitoneal de PTZ (60 mg/kg). Por vinte minutos os animais foram monitorados para a avaliação dos tempos de latência para o primeiro espasmo mioclônico e a primeira crise tônico-clônica, como também o tempo de duração das convulsões e de sobrevida. A análise eletroencefalográfica foi utilizada para avaliar a severidade das crises (aumento da amplitude das ondas). Após esse período os animais foram sacrificados, o córtex cerebral dissecado e análises bioquímicas (atividade da superóxido desmutase (SOD), catalase (CAT), níveis de nitritos e peroxidação lipídica) foram feitas para investigação dos mecanismos pelos quais a droga influencia as convulsões. Os resultados preliminares demonstraram que a duloxetina apresenta atividade anticonvulsivante, sendo capaz de aumentar significativamente o tempo de latência tanto para o primeiro espasmo clônico, como para a primeira convulsão tônico-clônica induzidas pelo pentilenotetrazol. Ainda a avaliação eletroencefalográfica demonstrou que a duloxetina na dose de 20 mg/kg diminuiu significativamente a amplitude das ondas enquanto a dose de 40 mg/kg aumentou significativamente a amplitude em comparação a todos os tratamentos. Quanto à avaliação da influência no estresse oxidativo, animais tratados apenas com PTZ apresentaram um aumento significativo do nível de peroxidação lipídica, e diminuição da atividade da SOD e da CAT. Quanto ao nível de nitritos não houve nenhuma alteração significativa entre os tratamentos. A duloxetina na dose de 20 mg/kg se mostrou efetiva para evitar as alterações induzidas pelo PTZ nos parâmetros de estresse oxidativo avaliados. A atividade anticonvulsivante da duloxetina (20 mg/kg) colabora com a teoria que tem sido apresentada nos últimos ano de que a modulação da neurotransmissão serotonérgica e noradrenérgica pode ter efeito anticonvulsivante. Ainda, a capacidade da duloxetina de inibir a exacerbação do estresse oxidativo envolvido nas convulsões induzidas pelo PTZ corrobora com estudos que demonstram que algumas substâncias anticonvulsivantes podem modular as convulsões pelo menos em parte por sua atividade antioxidante. Portanto concluímos que a duloxetine é um adjuvante promissor para o tratamento de pacientes que apresentam a comorbidade epilepsia e depressão.

Leishmanicidal activity of the crude extract, fractions and major piperidine alkaloids from the flowers of Senna spectabilis

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Análise de atividade epileptiforme com uso simultâneo de eletrencefalografia e ressonância magnética funcional

The use of multimodal neuroimaging techniques has been helpful in the investigation of epileptogenic zone in patients with refractory epilepsies. This work aims to describe an ictal event during EEG-fMRI performed simultaneously in a 39-year-old man with refractory epilepsy. The EEG data were recorded at a sampling rate of 5 kHz, using a BrainAmp (BrainProducts, München, Germany) amplifier, with 64 MR (magnetic resonance) compatible Ag/AgCl electrodes. MR images were acquired using a 3T scanner in 3 sequences of 6 minutes of echo-planar images (EPIs), with TR = 2s, being the last sequence stopped after the ictal event. The EEG was corrected for gradient and pulse artifacts using the Brain Vision Analyzer2 software (BrainProducts), and the functional images were realigned, slice-timing corrected, normalized and smoothed. The start of the ictal changes was used for the evaluation of the BOLD response in MR images, using a t-test with a minimum cluster of 5 voxels, p <0.005 (T>2.5). The patient had a partial complex seizure, as noted by neurologist. The fMRI data showed positive BOLD responses (activation) in dysplastic areas, but showed the most significant activation outside the lesion, in areas compatible with secondary spread of the epileptic focus, probably caused by motor reaction also observed during the seizure. As a conclusion, we note that the technique of EEG-fMRI can detect the epileptogenic zone in patients with refractory epilepsy, but areas of dissemination of primary epileptogenic focus may show significant activation, introducing additional difficulties to the interpretation of the results

Tratamento farmacológico da epilepsia em cães

Seizure is a clinical manifestation of abnormal neuronal hyperactivity of the cerebral cortex, presentation clinical varies according to the location and extent of the brain. The classic seizure begins with an inicial period, named prodrome, followed by the aura, the ictus and finally the post-ictus phase. Seizures can be generalized or focal/partial types. Focal seizures with secondary generalization are the most common type in dogs. The seizure can be divided etiologically in intracraneal (idiopathic epilepsy; sintomatic; probably sintomatic epilepsy) and extracraneal disorders. After determining the etiology of seizures and critical analysis of the frequency, severity, and worry they cause to the owner, you should make the decision whether to launch an anticonvulsant drug therapy. Although the ideal is the elimination of seizures, the real goal should be to decrease the frequency and intensity of crises, without affecting the quality of life of patients taking the drugs used side effects acceptable. The veterinary should consider the bioavailability of the drug, contraindications, toxicity, drug interactions, the amount of daily administration, the availability of the owner and the cost of therapy. Seizures can be controlled in about 70- 80% of the dogs and in the majority of the cats when treated with Phenobarbital alone. Addition of a second drug (usually potassium bromide), decreases the number of seizures in more that 50% in about 70-80% of dogs. However, approximately 20-30% of dogs are refractory to this treatment. In these cases, it will be necessary to think in other pharmacological alternatives, like felbamate, gabapentin, levetiracetam, zonisamid, among others. It has been concluded that... (Complete abstract click eletronic access below)

Fatores que influenciam a qualidade de vida de pessoas com epilepsia

Epilepsy is a chronic disorder that impairs life quality (LQ) and interferes in emotional, personal, social and family relationship aspects. This study evaluated 165 people with epilepsy diagnosis, ranging from 18 to 75 years old (M=41,28; SD= 13,26), by means of the QQV-65 (Life Quality Questionnaire with 65 questions) and investigated the association between the questionnaire scores and the disease features, comparing patients who showed refrectory seizures with patients with partially controled seizures. There was no difference in relation to the two groups regarding the LQ factor. The QQV-65 emotional factor was the most affected in both groups, since the estimated mean z-escore was 51,0±14,4 for Group I and 49,9±14,7 for Group II. Regarding the type of crisis, the analysis of variance (ANOVA) revealed that Health was the only factor in QQV-65 that showed a statistically significant difference between the z-scores (P = 0.024). However, for the frequency of epileptic seizures, except Health (P = 0.185), other factors QQV-65 proved to be related in a statistically significant way (P> 0.05). The research demonstrated that seizure control perception is quite important in the evaluation of life quality in all its aspects (health, body, society, emotion, locus of control, self-concept and cognition).

Qualidade de vida de crianças e adolescentes com epilepsia no município de Maringá

Pós-graduação em Saúde Coletiva - FMB

Risk evaluation of diabetes mellitus by relation of chaotic globals to HRV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Analysis of generalized interictal discharges using quantitative EEG

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Small calcified lesions suggestive of neurocysticercosis are associated with mesial temporal sclerosis

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Avaliação da atividade antioxidante, fotoprotetora e antiglicante dos extratos das folhas e flores de Moringa oleifera

Pós-graduação em Biociências - FCLAS

Metabolic parameters of rats prone to display wild-running of the audiogenic crisis and fighting induced by REM-sleep deprivation

Fundação de Apoio à Pesquisa do Estado de São Paulo (FAPESP)

Imagem de tensor de difusão na epilesia de lobo temporal mesial

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Análise quantitativa das descargas epileptiformes generalizadas e da neuroimagem de pacientes com epilepsia generalizada idiopática

Pós-graduação em Fisiopatologia em Clínica Médica - FMB

Can the `yin and yang` BDNF hypothesis be used to predict the effects of rTMS treatment in neuropsychiatry?

Repetitive transcranial magnetic stimulation (rTMS) is a novel technique of non-invasive brain stimulation which has been used to treat several neuropsychiatric disorders such as major depressive disorder, chronic pain and epilepsy. Recent studies have shown that the therapeutic effects of rTMS are associated with plastic changes in local and distant neural networks. In fact, it has been suggested that rTMS induces long-term potentiation (LTP) and long-term depression (LTD) - like effects. Besides the initial positive clinical results; the effects of rTMS are stilt mixed. Therefore new toots to assess the effects of plasticity non-invasively might be useful to predict its therapeutic effects and design novel therapeutic approaches using rTMS. In this paper we propose that brain-derived neurotrophic factor (BDNF) might be such a tool. Brain-derived neurotrophic factor is a neurotrophin that plays a key role in neuronal survival and synaptic strength, which has also been studied in several neuropsychiatric disorders. There is robust evidence associating BDNF with the LTP/LTD processes, and indeed it has been proposed that BNDF might index an increase or decrease of brain activity - the `yin and yang` BDNF hypothesis. In this article, we review the initial studies combining measurements of BDNF in rTMS clinical trials and discuss the results and potential usefulness of this instrument in the field of rTMS. (C) 2008 Elsevier Ltd. All rights reserved.

Late Adverse Effects of the Coadministration of Valproate and Lamotrigine

Individuals treated with combined valproate-lamotrigine rarely present late adverse effects (unrelated to introduction and titration). We describe four patients in whom such effects occurred after continuous, long-term use of valproate-lamotrigine (at 9 months to 2 years after final antiepileptic drug adjustment). The patients presented heterogeneous disturbances, including ataxia, vertigo, and headache, and rare movement disorders, such as tics and abnormal eye movements. Although these effects are heterogeneous in their occurrence and timing, they can alert physicians to the possibility of late neurologic disturbances, and must be considered in order to avoid unnecessary ancillary tests. Treatment discontinuation is unnecessary, given that a small decrease in dose led to remission of these adverse effects. (c) 2012 Elsevier Inc. All rights reserved.